Cost, Economics and Databases of Pharmaceutical Drugs in Public Health: Second Edition
A special issue of Healthcare (ISSN 2227-9032).
Deadline for manuscript submissions: 15 August 2024 | Viewed by 95
Special Issue Editor
Interests: pharmacology; pharmacoeconomics; medical and drug databases; quality of life; EBM; RWE; therapy costs
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Public health does not only concern patients and medical procedures aimed at improving the health of the population, subpopulations, and target groups in terms of treating disease. Rather, it includes issues such as the quality of life, the costs of procedures, disease prevention, and drugs. These issues are critical elements of national, continental and global healthcare strategies, as perfectly demonstrated by the COVID-19 pandemic.
Pharmacoeconomics, health economics, and medical decision economics are just some of the essential elements of medical strategy, which is perceived differently in different countries.
This Special Issue, entitled “Cost, Economics and Databases of Pharmaceutical Drugs in Public Health: Second Edition”, offers a unique opportunity to show the multifaceted nature of this issue, starting from costs and ending with the use of medical databases and systematic reviews in the effective use or allocation of resources to treat patients (including drugs).
I cordially invite you and your staff to submit publications to this Special Issue.
Dr. Krzysztof Kus
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Insecurity
- Food
- Cosmetics
- Health
- Healthcare
- Medical device
- Dietary supplements
- Policies
- Assessment
- Databases
- Quality of life
- Real World Evidence (RWE)
- Evidence-Based Medicine (EBM)
- Pharmacy Evidence-Based (PEB)
- Therapy cost
- Economics
- Pharmacoeconomics
- Health economics
- Budget Impact Analyses
